On the contrary, the combined blockade of type 2 cytokines, namely, IL-13 and IL-25, was more effective than the obstruction of either cytokine in reducing the infiltration of inflammatory cells in the airways with attenuated airway hyperresponsiveness and tissue remodeling [30]. The gene discussed is IL13; the disease is airway hyperresponsiveness.